HHS Releases New Guidance on Direct-to-Patient Prescription Drug Sales
The new policy clarifies that such direct sales are considered low risk under the anti-kickback statute
- Published date: 01-02-2026 05:23 PM
The new policy clarifies that such direct sales are considered low risk under the anti-kickback statute